Back to results
US 2022/0177839 A1Published application
Composition, culture medium and method for inducing and/or amplifying tscm in vitro
OwnerJianqing Xu, Xiaoyan Zhang +1inventors
InventorsJianqing Xu, Xiaoyan Zhang, Qibin Liao
Life of this patent
Estimating the term…
Abstract
A composition for inducing and/or amplifying TSCM in vitro, a culture medium including the composition, and a method for inducing and/or amplifying TSCM in vitro are provided, wherein the composition comprises inducing agents including IL-7 and IL-21. The chimeric antigen receptor T-memory stem cells induced differentiated and amplified by adding the composition can be used directly for reinfusion therapy of patients.
Claims21
A composition for inducing and/or amplifying TSCM in vitro, the composition comprising inducing agents, the inducing agents comprising IL-7 and IL-21.
(canceled)
Dependencies are inferred from the claim text.